Madihah A. Hepburn

Madihah Hepburn practices at Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst.

Madihah Hepburn's NPI, 1417339383, was assigned on June 26, 2015. Madihah Hepburn holds Missouri license 2015020124.

Madihah Hepburn's primary practice is Summa Health System - Akron Campus, at 525 East Market Street, Akron, OH 44309 in Summit County. The practice phone is (330) 375-3000.

Madihah Hepburn's primary practice is Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst. The medical group on file is Summa Health Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Madihah Hepburn practices. Vendor and product names are available with a free account.

Neurology is Madihah Hepburn's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Madihah Hepburn is licensed in Missouri.

CMS data shows 171 Medicare services from Madihah Hepburn across 5 procedure codes in 2024, for 116 Medicare patients. Medicare paid $19,108 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Madihah Hepburn in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Madihah Hepburn's median patient age at 67, with 46% women.

In 2019, Madihah Hepburn wrote 22 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $393 in total drug cost. In 2018, CMS named 101 claims across 6 drugs.

Madihah Hepburn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Madihah Hepburn as offering telehealth.

CMS Open Payments shows 27 general payments to Madihah Hepburn from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 60% of the total. Janssen Research & Development, LLC paid the most, $1,136.